|
|
Volumn 13, Issue 1 PART II, 1998, Pages 157-169
|
|
Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression a 6-month double-blind study in a primary-care setting in France
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOXETINE;
SERTRALINE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
COST CONTROL;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
DRUG COST;
DRUG EFFICACY;
DRUG TOLERABILITY;
ECONOMIC EVALUATION;
FEMALE;
HEALTH INSURANCE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
1-NAPHTHYLAMINE;
ADOLESCENT;
ADULT;
AGED;
ANTIDEPRESSIVE AGENTS;
COSTS AND COST ANALYSIS;
DEPRESSIVE DISORDER;
DOUBLE-BLIND METHOD;
FEMALE;
FLUOXETINE;
FRANCE;
HUMANS;
MALE;
MIDDLE AGED;
QUALITY OF LIFE;
SEROTONIN UPTAKE INHIBITORS;
SERTRALINE;
|
|
EID: 0031963316
PISSN: 11707690
EISSN: None
Source Type: Journal
DOI: 10.2165/00019053-199813010-00015 Document Type: Article |
|
Times cited : (47)
|
|
References (2)
|
